Casi Pharmaceuticals, Inc.

CASIF·OTC·$0.11Share Price as of 11/2·$2MMarket Cap as of 11/2

Financials

20-FAnnual report (foreign)05/15/26 20-FAnnual report (foreign)03/31/25 20-FAnnual report (foreign)03/28/24 20-FAnnual report (foreign)04/26/23

Disclosures

6-KForeign issuer report09/02/26 6-KForeign issuer report08/14/26 6-KForeign issuer report08/13/26 6-KForeign issuer report07/15/26 6-KForeign issuer report06/29/26

Prospectuses and Registrations

424B5Prospectus supplement04/01/25 F-3/AShelf registration (foreign, amended)12/23/24 F-3Shelf registration (foreign)12/20/24 F-3/AShelf registration (foreign, amended)08/29/24 F-3Shelf registration (foreign)08/16/24

Proxies

No matching filings.

Ownership

SC 13D/ABeneficial ownership (amended)05/18/26 Form 3Initial insider ownership04/23/26 Form 3Initial insider ownership04/20/26 Form 3Initial insider ownership04/16/26 Form 3Initial insider ownership04/13/26

Other

25-NSERemoval from listing06/23/26 DD04/28/26 NT 20-FLate filing notification (20-F)04/21/26 DD02/26/26 DD01/28/26